SCD-iBIO, an industrial biotechnology group associated with the The event will be held
According to a release, as a member of the DSM team since 1994, Lubben is responsible for the global activities of the company's Bio- Based Chemicals & Materials business a group that brings together several global innovation teams focused on developing and commercializing renewable chemicals and downstream compounds. Lubben also serves as a board member of Reverdia, a large-scale facility for the commercial production of biobased succinic acid, which is a joint venture between DSM and Roquette.
"We are slowly, but certainly, starting the switch from a fossil- based to a bio-based economy," said Lubben. "Still at an early stage, it is clear there is no such thing as a silver bullet approach to force your way in. At DSM we believe that a profound understanding of the value chain and the integral relationship between biomass, products and applications are the most important keys to success in this emerging industry."
DSM is focused on the chemical industry sector in the Dow Jones Sustainability World Index and believes sustainability is about more than compliance and social responsibility. DSM has made sustainability a business driver for the company based on its core values.
"With the knowledge and expertise Dr. Lubben has gained as a leader in the biotechnology industry and as part of the DSM team, he is one of the few people in his field who is in a position to know where industrial biotechnology is today and where it can go in the future," said
SCD-iBIO, an affiliate of SOCMA, is a company member organization that advances the commercial development of industrial biotechnology, which is the application of biology for the environmentally friendly and economically sustainable production and processing of chemicals, pharmaceuticals, materials and energy.
((Comments on this story may be sent to firstname.lastname@example.org))
SCD-iBIO, an industrial biotechnology group associated with the
The event will be held